The assessment of cognitive and behavioural disturbances in vascular cognitive impairment (VCI) — recommendations of an expert working group
Abstract
With newer research-based classification systems, the term Vascular Cognitive Impairment (VCI) is now preferred to vascular dementia. VCI is an umbrella term that includes all forms of cognitive deficits ranging from mild cognitive impairment of vascular origin (VaMCI) to vascular dementia (VaD).
The new VCI construct takes into account the fact that in addition to single strategic infarcts, multiple infarcts, and leukoaraiosis, there are other mechanisms of cerebrovascular disease such as chronic hypoperfusion that might account for the pattern of cognitive deficits associated with vascular dementia. The key to defining the spectrum of VCI is neuropsychological testing, bedside or office-based clinical examination, and neuroimaging. The lack of specific cognitive tools that are sufficiently sensitive to detect subtle deficits makes the assessment of cognitive impairment difficult. Prospective cross-sectional and longitudinal studies of VCI from different settings are therefore required.
Although there have been few published reports, behavioural and psychological symptoms (BPS) are inherently present in VCI from the onset and during the course of the disease. Besides the type of population (i.e. clinical, community or nursing-home settings), the definition of VCI/VaD and the instruments used, and differences in the prevalence and pattern of BPS between various studies, could be due to other, often unconsidered, factors such as gender, age, education, use of medication and VCI/VaD severity.
Keywords: vascular dementiamild cognitive impairmentstrokecerebrovascular disorderscognitionbehaviourdementiamulti-infarctmixed dementia
References
- O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol. 2003; 2(2): 89–98.
- Graff-Radford J. Vascular Cognitive Impairment. Continuum (Minneap Minn). 2019; 25(1): 147–164.
- Frantellizzi V, Pani A, Ricci M, et al. Neuroimaging in Vascular Cognitive Impairment and Dementia: A Systematic Review. J Alzheimers Dis. 2020; 73(4): 1279–1294.
- Carnevale L, Lembo G. Innovative MRI Techniques in Neuroimaging Approaches for Cerebrovascular Diseases and Vascular Cognitive Impairment. Int J Mol Sci. 2019; 20(11).
- Gorelick PB, Scuteri A, Black SE, et al. American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42(9): 2672–2713.
- Bordet R, Ihl R, Korczyn AD, et al. Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus report. BMC Med. 2017; 15(1): 107.
- Diagnostic and statistical manual of mental disorders: DSM-5. Arlington, VA: American Psychiatric Association. ; 2017.
- World Health Organization. (2018). International classification of diseases for mortality and morbidity statistics (11th Revision). https://icd.who.int/browse11/l-m/en.
- Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 1992; 42(3 Pt 1): 473–480.
- Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993; 43(2): 250–260.
- Sachdev P, Kalaria R, O'Brien J, et al. Internationlal Society for Vascular Behavioral and Cognitive Disorders. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014; 28(3): 206–218.
- Sachdev PS, Lipnicki DM, Crawford JD, et al. The Vascular Behavioral and Cognitive Disorders criteria for vascular cognitive disorders: a validation study. Eur J Neurol. 2019; 26(9): 1161–1167.
- Gladman JT, Corriveau RA, Debette S, et al. Vascular contributions to cognitive impairment and dementia: Research consortia that focus on etiology and treatable targets to lessen the burden of dementia worldwide. Alzheimers Dement (N Y). 2019; 5: 789–796.
- Gupta M, Dasgupta A, Khwaja GA, et al. Behavioural and psychological symptoms in poststroke vascular cognitive impairment. Behav Neurol. 2014; 2014: 430128.
- Kalaria RN, Maestre GE, Arizaga R, et al. World Federation of Neurology Dementia Research Group. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008; 7(9): 812–826.
- Ruitenberg A, Ott A, van Swieten JC, et al. Incidence of dementia: does gender make a difference? Neurobiol Aging. 2001; 22(4): 575–580.
- Andersen K, Launer LJ, Dewey ME, et al. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology. 1999; 53(9): 1992–1997.
- Chan KY, Wang W, Wu JJ, et al. Global Health Epidemiology Reference Group (GHERG). Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet. 2013; 381(9882): 2016–2023.
- Esmael A, Elsherief M, Eltoukhy K. Prevalence of cognitive impairment in acute ischaemic stroke and use of Alberta Stroke Programme Early CT Score (ASPECTS) for early prediction of post-stroke cognitive impairment. Neurol Neurochir Pol. 2021 [Epub ahead of print].
- Rockwood K, Wentzel C, Hachinski V, et al. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology. 2000; 54(2): 447–451.
- Rincon F, Wright CB. Vascular cognitive impairment. Curr Opin Neurol. 2013; 26(1): 29–36.
- Vasquez BP, Zakzanis KK. The neuropsychological profile of vascular cognitive impairment not demented: a meta-analysis. J Neuropsychol. 2015; 9(1): 109–136.
- Edwards JD, Jacova C, Sepehry AA, et al. A quantitative systematic review of domain-specific cognitive impairment in lacunar stroke. Neurology. 2013; 80(3): 315–322.
- Andriuta D, Roussel M, Barbay M, et al. Godefroy and GRECogVASC study group. Differentiating between Alzheimer’s disease and vascular cognitive impairment: Is the “memory versus executive function” contrast still relevant? J Alzheimers Dis. 2018; 63(2): 625–33.
- Libon D, Price C, Swenson R, et al. Vascular Cognitive Impairment. Neurovascular Neuropsychology. 2009: 75–86.
- Schmahmann JD. Vascular syndromes of the thalamus. Stroke. 2003; 34(9): 2264–2278.
- Chen Y, Wang A, Tang J, et al. Association of white matter integrity and cognitive functions in patients with subcortical silent lacunar infarcts. Stroke. 2015; 46(4): 1123–1126.
- Liu X, Cheng R, Chen Li, et al. Alterations of White Matter Integrity in Subcortical Ischemic Vascular Disease with and Without Cognitive Impairment: a TBSS Study. J Mol Neurosci. 2019; 67(4): 595–603.
- Du J, Wang Y, Zhi N, et al. Structural brain network measures are superior to vascular burden scores in predicting early cognitive impairment in post stroke patients with small vessel disease. Neuroimage Clin. 2019; 22: 101712.
- Sang L, Liu C, Wang Li, et al. Disrupted Brain Structural Connectivity Network in Subcortical Ischemic Vascular Cognitive Impairment With No Dementia. Front Aging Neurosci. 2020; 12: 6.
- Chen Qi, Wang Y, Qiu Y, et al. A Deep Learning-Based Model for Classification of Different Subtypes of Subcortical Vascular Cognitive Impairment With FLAIR. Front Neurosci. 2020; 14: 557.
- Vinciguerra L, Lanza G, Puglisi V, et al. Transcranial Doppler ultrasound in vascular cognitive impairment-no dementia. PLoS One. 2019; 14(4): e0216162.
- Giorgio A, Di Donato I, De Leucio A, et al. VMCI-Tuscany Study Group. Relevance of brain lesion location for cognition in vascular mild cognitive impairment. Neuroimage Clin. 2019; 22: 101789.
- Weaver NA, Zhao L, Biesbroek JM, et al. Meta VCI Map consortium. The Meta VCI Map consortium for meta-analyses on strategic lesion locations for vascular cognitive impairment using lesion-symptom mapping: Design and multicenter pilot study. Alzheimers Dement (Amst). 2019; 11: 310–326.
- Tales A, Snowden RJ, Haworth J, et al. Abnormal spatial and non-spatial cueing effects in mild cognitive impairment and Alzheimer's disease. Neurocase. 2005; 11(1): 85–92.
- Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006; 37(9): 2220–2241.
- Barbay M, Taillia H, Nédélec-Ciceri C, et al. GRECOG-VASC Study Group. Prevalence of Poststroke Neurocognitive Disorders Using National Institute of Neurological Disorders and Stroke-Canadian Stroke Network, VASCOG Criteria (Vascular Behavioral and Cognitive Disorders), and Optimized Criteria of Cognitive Deficit. Stroke. 2018; 49(5): 1141–1147.
- Pendlebury ST, Mariz J, Bull L, et al. MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke. Stroke. 2012; 43(2): 464–469.
- Arevalo-Rodriguez I, Smailagic N, Roqué I Figuls M, et al. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015(3): CD010783.
- Sokołowska N, Sokołowski R, Oleksy E, et al. Usefulness of the Polish versions of the Montreal Cognitive Assessment 7.2 and the Mini-Mental State Examination as screening instruments for the detection of mild neurocognitive disorder. Neurol Neurochir Pol. 2020; 54(5): 440–448.
- Koski L. Validity and applications of the Montreal cognitive assessment for the assessment of vascular cognitive impairment. Cerebrovasc Dis. 2013; 36(1): 6–18.
- Potocnik J, Ovcar Stante K, Rakusa M. The validity of the Montreal cognitive assessment (MoCA) for the screening of vascular cognitive impairment after ischemic stroke. Acta Neurol Belg. 2020; 120(3): 681–685.
- Chan E, Khan S, Oliver R, et al. Underestimation of cognitive impairments by the Montreal Cognitive Assessment (MoCA) in an acute stroke unit population. J Neurol Sci 2014;343(1–2. : 176–9.
- Chan E, Altendorff S, Healy C, et al. The test accuracy of the Montreal Cognitive Assessment (MoCA) by stroke lateralisation. J Neurol Sci. 2017; 373: 100–104.
- Lim JS, Oh MiS, Lee JH, et al. Prediction of post-stroke dementia using NINDS-CSN 5-minute neuropsychology protocol in acute stroke. Int Psychogeriatr. 2017; 29(5): 777–784.
- Chen X, Wong A, Ye R, et al. Validation of NINDS-CSN neuropsychological battery for vascular cognitive impairment in Chinese stroke patients. BMC Neurol. 2015; 15: 20.
- Kessler, J., Calabrese, P., Kalbe, E. and Berger. F. DemTect. Ein neues Screening-Verfahren zur Unterstützung der Demenzdiagnostik. Psycho. 2000; 6: 343–347.
- Kalbe E, Kessler J, Calabrese P, et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry. 2004; 19(2): 136–143.
- Wojtyńska R, Szcześniak D. DemTect®--effective to asses MCI and dementia--validation study of the Polish language version. Aging Ment Health. 2016; 20(5): 510–516.
- Kessler J, Calabrese P, Kalbe E. DemTect-B: ein Äquivalenztest zum kognitiven Screening DemTect-A®. Fortschritte der Neurologie · Psychiatrie. 2010; 78(09): 532–535.
- Kessler J, Fengler S, Kaesberg S, et al. DemTect 40– und DemTect 80+: Neue Auswertungsroutinen für diese Altersgruppen. Fortschritte der Neurologie · Psychiatrie. 2014; 82(11): 640–645.
- Dobbs BM, Schopflocher D. The Introduction of a New Screening Tool for the Identification of Cognitively Impaired Medically At-Risk Drivers: The SIMARD A Modification of the DemTect. J Prim Care Community Health. 2010; 1(2): 119–127.
- Kalbe E, Calabrese P, Fengler S, et al. DemTect, PANDA, EASY, and MUSIC: cognitive screening tools with age correction and weighting of subtests according to their sensitivity and specificity. J Alzheimers Dis. 2013; 34(4): 813–834.
- Kalbe E, Calabrese P, Schwalen S, et al. The Rapid Dementia Screening Test (RDST): a new economical tool for detecting possible patients with dementia. Dement Geriatr Cogn Disord. 2003; 16(4): 193–199.
- Brookes RL, Hannesdottir K, Lawrence R, et al. Brief Memory and Executive Test: evaluation of a new screening test for cognitive impairment due to small vessel disease. Age Ageing. 2012; 41(2): 212–218.
- Ghafar MZ, Miptah HN, O'Caoimh R. Cognitive screening instruments to identify vascular cognitive impairment: A systematic review. Int J Geriatr Psychiatry. 2019; 34(8): 1114–1127.
- Demeyere N, Riddoch MJ, Slavkova ED, et al. The Oxford Cognitive Screen (OCS): validation of a stroke-specific short cognitive screening tool. Psychol Assess. 2015; 27(3): 883–894.
- Benaim C, Barnay JL, Wauquiez G, et al. The Cognitive Assessment scale for Stroke Patients (CASP) vs. MMSE and MoCA in non-aphasic hemispheric stroke patients. Ann Phys Rehabil Med. 2015; 58(2): 78–85.
- Barnay JL, Wauquiez G, Bonnin-Koang HY, et al. Feasibility of the cognitive assessment scale for stroke patients (CASP) vs. MMSE and MoCA in aphasic left hemispheric stroke patients. Ann Phys Rehabil Med. 2014; 57(6-7): 422–435.
- Tan LP, Herrmann N, Mainland BJ, et al. Can clock drawing differentiate Alzheimer's disease from other dementias? Int Psychogeriatr. 2015; 27(10): 1649–1660.
- Richards E, Bayer A, Hanley C, et al. Reaction Time and Visible White Matter Lesions in Subcortical Ischemic Vascular Cognitive Impairment. J Alzheimers Dis. 2019; 72(3): 859–865.
- Skrobot OA, Black SE, Chen C, et al. VICCCS group. Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement. 2018; 14(3): 280–292.
- Van Heugten CM, Walton L, Hentschel U. Can we forget the Mini-Mental State Examination? A systematic review of the validity of cognitive screening instruments within one month after stroke. Clin Rehabil. 2015; 29(7): 694–704.
- Abbate C, Trimarchi PD, Inglese S, et al. Signs and symptoms method in neuropsychology: A preliminary investigation of a standardized clinical interview for assessment of cognitive decline in dementia. Appl Neuropsychol Adult. 2021; 28(3): 282–296.
- Bickerton WL, Demeyere N, Francis D, et al. The BCoS cognitive profile screen: Utility and predictive value for stroke. Neuropsychology. 2015; 29(4): 638–648.
- Schmid NS, Ehrensperger MM, Berres M, et al. The Extension of the German CERAD Neuropsychological Assessment Battery with Tests Assessing Subcortical, Executive and Frontal Functions Improves Accuracy in Dementia Diagnosis. Dement Geriatr Cogn Dis Extra. 2014; 4(2): 322–334.
- Korczyn AD. Mixed dementia--the most common cause of dementia. Ann N Y Acad Sci. 2002; 977: 129–134.
- Yu L, Boyle PA, Leurgans S, et al. Effect of common neuropathologies on progression of late life cognitive impairment. Neurobiol Aging. 2015; 36(7): 2225–2231.
- Schneider JA, Bennett DA. Where vascular meets neurodegenerative disease. Stroke. 2010; 41(10 Suppl): S144–S146.
- Dong Y, Gan DZ, Tay SZ, et al. Patterns of neuropsychological impairment in Alzheimer's disease and mixed dementia. J Neurol Sci. 2013; 333(1-2): 5–8.
- Boomsma JMF, Exalto LG, Barkhof F, et al. behalf of the TRACE-VCI study group. How Do Different Forms of Vascular Brain Injury Relate to Cognition in a Memory Clinic Population: The TRACE-VCI Study. J Alzheimers Dis. 2019; 68(3): 1273–1286.
- Chander RJ, Foo H, Yong T, et al. Serial position effects differ between Alzheimer's and vascular features in mild cognitive impairment. Aging (Albany NY). 2018; 10(12): 3866–3880.
- Ikeda M, Fukuhara R, Shigenobu K, et al. Dementia associated mental and behavioural disturbances in elderly people in the community: findings from the first Nakayama study. J Neurol Neurosurg Psychiatry. 2004; 75(1): 146–148.
- Caputo M, Monastero R, Mariani E, et al. Neuropsychiatric symptoms in 921 elderly subjects with dementia: a comparison between vascular and neurodegenerative types. Acta Psychiatr Scand. 2008; 117(6): 455–464.
- Srikanth S, Nagaraja AV, Ratnavalli E. Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia. J Neurol Sci. 2005; 236(1-2): 43–48.
- Hsieh CJ, Chang CC, Lin CC. Neuropsychiatric profiles of patients with Alzheimer's disease and vascular dementia in Taiwan. Int J Geriatr Psychiatry. 2009; 24(6): 570–577.
- Fuh JL, Wang SJ, Cummings JL. Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia. J Neurol Neurosurg Psychiatry. 2005; 76(10): 1337–1341.
- Fernández-Martínez M, Castro J, Molano A, et al. Prevalence of neuropsychiatric symptoms in Alzheimer's disease and vascular dementia. Curr Alzheimer Res. 2008; 5(1): 61–69.
- Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol. 1975; 32(9): 632–637.
- Staekenborg SS, Su T, van Straaten ECW, et al. Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease. J Neurol Neurosurg Psychiatry. 2010; 81(5): 547–551.
- Anor CJ, O'Connor S, Saund A, et al. Neuropsychiatric Symptoms in Alzheimer Disease, Vascular Dementia, and Mixed Dementia. Neurodegener Dis. 2017; 17(4-5): 127–134.
- Manso-Calderón R, Cacabelos-Pérez P, Sevillano-García MD, et al. The impact of vascular burden on behavioural and psychological symptoms in older adults with dementia: the BEVASDE study. Neurol Sci. 2020; 41(1): 165–174.
- Aalten P, Verhey FRJ, Boziki M, et al. Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II. Dement Geriatr Cogn Disord. 2008; 25(1): 1–8.
- Johnson DK, Watts AS, Chapin BA, et al. Neuropsychiatric profiles in dementia. Alzheimer Dis Assoc Disord. 2011; 25(4): 326–332.
- Park JH, Lee SB, Lee TJ, et al. Depression in vascular dementia is quantitatively and qualitatively different from depression in Alzheimer's disease. Dement Geriatr Cogn Disord. 2007; 23(2): 67–73.
- Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997; 48(5 Suppl 6): S10–S16.
- Aben I, Verhey F, Lousberg R, et al. Validity of the beck depression inventory, hospital anxiety and depression scale, SCL-90, and hamilton depression rating scale as screening instruments for depression in stroke patients. Psychosomatics. 2002; 43(5): 386–393.
- Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9): 606–613.
- Radloff L. The CES-D Scale. Applied Psychological Measurement. 2016; 1(3): 385–401.
- Benaim C, Cailly B, Perennou D, et al. Validation of the aphasic depression rating scale. Stroke. 2004; 35(7): 1692–1696.
- Turner-Stokes L, Kalmus M, Hirani D, et al. The Depression Intensity Scale Circles (DISCs): a first evaluation of a simple assessment tool for depression in the context of brain injury. J Neurol Neurosurg Psychiatry. 2005; 76(9): 1273–1278.
- Sagen U, Vik TG, Moum T, et al. Screening for anxiety and depression after stroke: comparison of the hospital anxiety and depression scale and the Montgomery and Asberg depression rating scale. J Psychosom Res. 2009; 67(4): 325–332.
- Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res. 1991; 38(2): 143–162.
- Douven E, Köhler S, Schievink SHJ, et al. Baseline Vascular Cognitive Impairment Predicts the Course of Apathetic Symptoms After Stroke: The CASPER Study. Am J Geriatr Psychiatry. 2018; 26(3): 291–300.
- Kim JM, Lyons D, Shin IS, et al. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable? Hum Psychopharmacol. 2003; 18(3): 215–220.
- Kaufer DI, Cummings JL, Christine D, et al. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale. J Am Geriatr Soc. 1998; 46(2): 210–215.
- Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980; 20(6): 649–655.
- Salvadori E, Poggesi A, Pracucci G, et al. VMCI-Tuscany Study Group. Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients. Dement Geriatr Cogn Dis Extra. 2018; 8(1): 104–116.
- Molad J, Hallevi H, Korczyn AD, et al. Vascular and Neurodegenerative Markers for the Prediction of Post-Stroke Cognitive Impairment: Results from the TABASCO Study. J Alzheimers Dis. 2019; 70(3): 889–898.
- McFall A, Hietamies TM, Bernard A, et al. UK consensus on pre-clinical vascular cognitive impairment functional outcomes assessment: Questionnaire and workshop proceedings. J Cereb Blood Flow Metab. 2020; 40(7): 1402–1414.
![](https://journals.viamedica.pl/plugins/generic/popups/images/icons/close.png)